|
FY2025
12 months to Dec 31, 2025
|
FY2023
12 months to Jun 30, 2024
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|
| Cash Flows from Operating Activities: | ||||
| Net loss | ||||
| Adjustments to reconcile net loss to net cash used in operating activities: | ||||
| Stock-based compensation | ||||
| Change in fair value of derivative liabilities | ||||
| Changes in operating assets and liabilities: | ||||
| Prepaid expenses and other receivable | ||||
| Accounts payable - related party | ||||
| Other payables and accrued liabilities | ||||
| Accrued liability - related party | ||||
| Franchise tax payable | ||||
| Income tax payables | ||||
| Net cash used in operating activities | ||||
| Loan to UPTD as extension note receivable prior to business combination | ||||
| Cash released from trust account | ||||
| Net cash provided by investing activities | ||||
| Cash Flows from Financing Activities: | ||||
| Payments of transactions cost | ||||
| Repayment on promissory note to related party | ||||
| Net proceeds from PIPE investment | ||||
| Net proceeds from issuance of Series A Preferred Stock | ||||
| Net proceeds from promissory note | ||||
| Repayment of promissory note | ||||
| Payment of redemption payable | ||||
| Proceeds from business combination | ||||
| Proceeds from issuance of common stock for PIPE investment | ||||
| Purchase of treasury stock | ||||
| Net cash provided by (used in) financing activities | ||||
| Net Change in Cash | ||||
| Cash at beginning of the year | ||||
| Cash at end of the year | ||||
| Supplemental Cash Flow Information | ||||
| Cash paid for income tax | ||||
| Cash paid for interest | ||||
| Conversion of Series A prefer stock into common stock | ||||
| Conversion of deferred underwriting commission payable into Series A preferred stock | ||||
| Supplemental Disclosure of Non-cash Financing Activities | ||||
| Recognition of derivative liabilities upon closing of the PIPE investment | ||||
Loading...